From the Journals

Frequent visits to green spaces linked to lower use of some meds


 

Evidence mounts on the benefits of nature

There is growing evidence that exposure to nature could benefit human health, especially mental and cardiovascular health, says Jochem Klompmaker, PhD, a postdoctoral researcher in the department of environmental health at the Harvard T.H. Chan School of Public Health, Boston.

Dr. Klompmaker has researched the association between exposure to green spaces and health outcomes related to neurological diseases.

In a study recently published in JAMA Network Open, and reported by this news organization, Dr. Klompmaker and his team found that among a large cohort of about 6.7 million fee-for-service Medicare beneficiaries in the United States aged 65 or older, living in areas rich with greenery, parks, and waterways was associated with fewer hospitalizations for certain neurological disorders, including Parkinson’s disease, Alzheimer’s disease, and related dementias.

Commenting on the current study, Dr. Klompmaker noted its strengths.

“A particular strength of this study is that they used data about the amount of green and blue spaces around the residential addresses of the participants, data about green space visit frequency, and data about green and blue views from home. Most other studies only have data about the amount of green and blue spaces in general,” he said.

“The strong protective associations of frequency of green space visits make sense to me and indicate the importance of one’s actual nature exposure,” he added. “Like the results of our study, these results provide clinicians with more evidence of the importance of being close to nature and of encouraging patients to take more walks. If they live near a park, that could be a good place to be more physically active and reduce stress levels.”

The study was supported by the Academy of Finland and the Ministry of the Environment. Dr. Turunen and Dr. Klompmaker report no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Noninvasive liver test may help select asymptomatic candidates for heart failure tests
MDedge Family Medicine
Angioedema risk jumps when switching HF meds
MDedge Family Medicine
Elevated PCSK9 levels associated with psoriasis suggest new treatment target
MDedge Family Medicine
Long QT syndrome overdiagnosis persists
MDedge Family Medicine
Autism linked to problems with cardiovascular health
MDedge Family Medicine
The long-range thrombolysis forecast calls for tiny ultrasonic tornadoes
MDedge Family Medicine
CV deaths jumped in 2020, reflecting pandemic toll
MDedge Family Medicine
Universal testing for Lp(a): What are we waiting for?
MDedge Family Medicine
The new blood pressure target in primary care
MDedge Family Medicine
Legacy ICDs exposed to MRI still shock, pace as needed
MDedge Family Medicine